Echis ocellatus snake venom metalloproteinase (EoSVMP)

Echis ocellatus snake venom metalloproteinases (EoSVMPs) are a diverse group of zinc-dependent enzymes that serve as the primary drivers of morbidity and mortality following envenomation by the West African carpet viper (Echis ocellatus) (Wagstaff et al., 2009, Gene). These enzymes are categorized into P-I, P-II, and P-III classes based on their domain architecture, which includes a catalytic metalloproteinase domain and, in larger classes, disintegrin-like and cysteine-rich domains (Casewell et al., 2011, Toxicon). Their primary biological function involves the rapid degradation of extracellular matrix (ECM) components, particularly the basement membrane of vascular endothelial cells, leading to localized and systemic hemorrhage (Gutiérrez et al., 2016, Toxins). Additionally, certain EoSVMPs act as potent prothrombin activators, contributing to venom-induced consumption coagulopathy (VICC) (Howes et al., 2005, Thrombosis and Haemostasis). In a therapeutic context, EoSVMPs are the primary targets for polyvalent and monovalent antivenoms, and they are increasingly being targeted by small-molecule matrix metalloproteinase inhibitors (MMPIs) like batimastat and marimastat to provide rapid, field-deployable treatment (Albulescu et al., 2020, Journal of Medicinal Chemistry). The development of these inhibitors represents a shift toward oral or heat-stable therapies that can be administered immediately after a bite, potentially bridging the gap between envenomation and hospital-based antivenom treatment (Ainsworth et al., 2018, Communications Biology).

Other names

West African carpet viper venom metalloproteinasesEchis ocellatus SVMPsReprolysin-type metalloproteinasesEcarin-like prothrombin activatorsEchiarin

Inhibition of the zinc-dependent catalytic site through chelation of the essential zinc ion or antibody-mediated neutralization of the enzyme surface, preventing the degradation of basement membrane proteins and the activation of pro-coagulant factors (Albulescu et al., 2020, Journal of Medicinal Chemistry; Gutiérrez et al., 2017, Nature Reviews Disease Primers).